Global Point Of Care Diagnostics Market By Product type & By Platform

1. Global Point Of Care Diagnostics Market to Reach at US$ 51.94 billion by 2028 Point-of-care (POC) tests are performed outside of central laboratories and provide immediate findings. POC has long been a goal in IVD (in vitro diagnostics), and new technologies have made it practicable. Point-of-care testing is changing as a result of advancements in smartphones, biosensors, lab-on-a-chip, and wearable devices. Having a quicker diagnosis is critical for healthcare workers. Point-of-care diagnostics is a component of a paradigm shift away from curative treatment and toward predictive, personalized, and preventive medicine.The growing importance of point-of-care diagnostics in environmental monitoring and public health necessitates the incorporation of technologies that enable simple networking, making it easier for healthcare practitioners to interpret test findings appropriately. Companies are working on developing low-cost POC with excellent specificity and sensitivity. Adoption of Advanced Instruments to Take the Lead in the Hospital Segment In 2020, the hospital segment dominated the global point of care diagnostics market. This is primarily owing to the increasing use of modern instruments in these settings, as well as substantial investments in hospital infrastructure in emerging countries by the public and private sectors. This increases demand for kits and instruments in present globalmarket conditions.The urgent care & clinics market is predicted to grow at a rapid pace. The move from primary care facilities to urgent care clinics for rapid infectious illness detection, as well as the expanding number of urgent care centers in many developed countries are driving the point of care diagnostics market. Get Free Sample PDF:https://skyquestt.com/sample-request/point-of-care-diagnostics-market Read market research report, " Global Point of care diagnostics Market” by Product type (Glucose Testing, Hb1Ac Testing, Coagulation Testing, Fertility/Pregnancy, Infectious Disease, Cardiac Markers, Thyroid Stimulating Hormone, Hematology, Primary Care Systems, Decentralized Clinical Chemistry, Feces, Lipid Testing, Cancer Marker, Blood Gas/Electrolytes, Ambulatory Chemistry, Urinalysis/Nephrology), By End Users (Clinics, Hospitals, Homecare, Assisted living healthcare facilities, Laboratory), By Platform (Lateral Flow Assay, Dipsticks, Microfluidics, Molecular diagnostics, Immunoassays)— Forecast and Analysis 2022–2028” by SkyQuest. Drug of Abuse (DOA) Testing,

2. North America is estimated to dominate the global point of care diagnostics market over the forecast period, contributing US$ 14.48 billion in 2021. The market in the region is expected to expand as a result of widespread usage of cutting-edge point-of-care diagnostics to identify a wide range of infectious and chronic diseases, as well as the availability of favorable reimbursement policies. Europe is predicted to grow at a significant CAGR throughout the projection period, maintaining its globalmarket share. Major players in Europe are focusing on the development of rapid diagnostic instruments for the prompt diagnosis of infectious diseases. Furthermore, the government has committed R&D investments to help the diagnostics business with cutting-edge point-of-care diagnostic testing. The report published by SkyQuest Technology Consulting provides in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. Read Full Report Here: https://skyquestt.com/report/point-of-care-diagnostics-market Report Scope & Segmentation Report Attribute Details Growth Rate CAGR of 5.2% from 2021 to 2028 The base year for estimation 2021 Historical data 2016 – 2020 Forecast period 2021 to 2028 Report coverage Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis ●Global Point of care diagnostics Market by product type oGlucose Testing oHb1Ac Testing oCoagulation Testing oFertility/Pregnancy oInfectious Disease HIV POC Clostridium Difficile POC HBV POC Pneumonia or Streptococcus Associated Infections Segments covered

3. Respiratory Syncytial Virus (RSV) POC, HPV POC Influenza/Flu POC HCV POC MRSA POC TB and Drug-resistant TB POC HSV POC COVID-19 Other Infectious Diseases oCardiac Markers oThyroid Stimulating Hormone oHematology oPrimary Care Systems oDecentralized Clinical Chemistry oFeces oLipid Testing oCancer Marker oBlood Gas/Electrolytes oAmbulatory Chemistry oDrug of Abuse (DOA) Testing oUrinalysis/Nephrology ●Global Point of Care Diagnostics Market by end users oClinics oHospitals oHomecare oAssisted living healthcare facilities oLaboratory ●Global Point Of Care Diagnostics Market by Platform oLateral flow assay oDipsticks oMicrofluidics oMolecular diagnostics oImmunoassays Global Point Of Care Diagnostics Market by region North America US Canada Europe Germany France

4. UK Italy Spain Rest of Europe Asia Pacific China India Japan Rest of Asia Pacific Middle East & Africa South Africa Rest of Middle East & Africa Regional scope North America, Europe, Asia-Pacific (APAC), Latin America (LATAM), Middle East & Africa (MEA) Country scope U.S., Canada, Germany, France, UK, Italy, Spain, China, India, Japan, Brazil, GCC Countries, South Africa Abbott Laboratories (US) Siemens Healthineers AG (Germany) Quidel Corporation (US) F. Hoffman-La Roche Ltd. (Switzerland) Danaher Corporation (US) Becton, Dickinson and Company (US) Chembio Diagnostics (US) EKF Diagnostics (UK) Trinity Biotech plc (Ireland) Instrumentation Laboratory (US) Nova Biomedical (US) PTS Diagnostics (US) Sekisui Diagnostics (US) Thermo Fisher Scientific (US) BioMerieux S.A. (France) Elbit Systems Ltd. (Israel) Key companies profiled Customization scope Free report customization (15% Free customization) with purchase. Addition or alteration to country, regional & segment scope. Pricing and Reap the benefits of customized purchase options to fit your specific research

5. purchase options requirements. Speak To Our Analyst:https://skyquestt.com/speak-with-analyst/point-of-care-diagnostics-market ●What does this Report Deliver? Market Estimation for 20+ Countries Point of care diagnostics Market demand by Region, Sub-Region, and Country Customization on Segments, Regions, and Company Profiles 100+ tables, 150+ Figures Global, Regional and Country specific Point of care diagnostics Market Trends Comprehensive Mapping of Point of care diagnostics Market Parameters Attractive Investment Proposition in the Global Point of care diagnostics Market Industry Competitive Strategies Adopted by Point of care diagnostics Market Key Players Drivers, Restraints, Opportunities, Challenges, and the impact on the Retinal diseases’ therapeutics Market Size Market growth rate till 2028 Regulatory scenario, regional dynamics, and point of care diagnostics Market insights of leading countries in each region In-depth Market insights by Region and Country Market Segmentation Trend Analysis, Opportunities and Growth Porter’s five force analysis to know the market’s condition Pricing Analysis and Point of care diagnostics Market Sales Parent market analysis Product portfolio benchmarking About Us: SkyQuest Technology is leading growth consulting firm providing market intelligence, commercialization and technology services. It has 450+ happy clients globally. Contact Us: Address: 1 Apache Way, Westford, Massachusetts 01886 Phone: USA (+1) 617-230-0741 Email: sales@skyquestt.com